ORASURE TECHNOLOGIES, INC Public Float
ORASURE TECHNOLOGIES, INC (OSUR) had Public Float of $218.47 million as of 2025-06-30, per its 10-K filed 2026-03-09.
Financial Statements › Notes › Cover Page
dei:EntityPublicFloat · last filed 2026-03-09
- 2025-06-30: Entity Public Float $218.47M.
- 2024-06-30: Entity Public Float $314.84M.
- 2023-06-30: Entity Public Float $368.29M.
- 2022-06-30: Entity Public Float $197.74M.
| Period end | Entity Public Float |
|---|---|
| 2025-06-30 | $218.47M 10-K · filed 2026-03-09 |
| 2024-06-30 | $314.84M 10-K · filed 2025-03-07 |
| 2023-06-30 | $368.29M 10-K · filed 2024-03-11 |
| 2022-06-30 | $197.74M 10-K · filed 2023-03-03 |
| 2021-06-30 | $727.98M 10-K · filed 2022-03-01 |
| 2020-06-30 | $829.04M 10-K · filed 2021-03-01 |
| 2019-06-30 | $569.76M 10-K/A · filed 2020-03-05 |
| 2018-06-30 | $1.00B 10-K · filed 2019-02-28 |
| 2017-06-30 | $1.01B 10-K · filed 2018-02-28 |
| 2016-06-30 | $477.84M 10-K · filed 2017-03-14 |
| 2015-06-30 | $298.66M 10-K · filed 2016-03-14 |
| 2014-06-30 | $473.98M 10-K · filed 2015-03-12 |
| 2013-06-30 | $212.52M 10-K · filed 2014-03-14 |
| 2012-06-30 | $535.01M 10-K · filed 2013-03-13 |
| 2011-06-30 | $391.26M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Anika Therapeutics, Inc. (ANIK) | United States | $0.272B | -51.71 |
| Cytosorbents Corp (CTSO) | United States | $0.274B | -1.29 |
| TriSalus Life Sciences, Inc. (TLSI) | United States | $0.283B | -9.92 |
| InfuSystem Holdings, Inc (INFU) | United States | $0.253B | 22.52 |
| Mobia Medical, Inc. (MOBI) | United States | $0.293B | |
| TREACE MEDICAL CONCEPTS, INC. (TMCI) | United States | $0.297B | -4.32 |
| UTAH MEDICAL PRODUCTS INC (UTMD) | United States | $0.238B | 20.93 |
| PRO DEX INC (PDEX) | United States | $0.234B | 13.64 |
| Embecta Corp. (EMBC) | United States | $0.319B | 2.10 |
| Neuronetics, Inc. (STIM) | United States | $0.216B | -3.25 |